Abstract
Concerns about conflicts of interest have driven a wedge between academia and the pharmaceutical and devices industries. Although elevated concern for bias is justified, particularly when academics may affect drug sales, partnerships between industry and academia are essential to achieve the full promise of health improvement from the public investment in biomedical research. New models for such partnerships are developing and should be encouraged.
References
Harris, G. & Carey, B. Researchers fail to reveal full drug pay. The New York Times (8 June 2008).
Cosgrove, L., Bursztajn, H.J. & Krimsky, S. N. Engl. J. Med. 360, 2035–2036 (2009).
Lenzer, J. & Brownlee, S. Br. Med. J. 337, a930 (2008).
Zinner, D.E. & Campbell, E.G. J. Am. Med. Assoc. 302, 969–976 (2009).
Hauser, S.L. & Johnston, S.C. Ann. Neurol. 64, A13–A15 (2008).
Stevens, A.J., Jensen, J.J., Wyller, K., Chatterjee, S. & Rohrbaugh, M.L. N. Engl. J. Med. 364, 535–541 (2011).
Munos, B. Nat. Rev. Drug Discov. 8, 959–968 (2009).
Adams, C.P. & Brantner, V.V. Health Econ. 19, 130–141 (2008).
Vogel, G. Science 276, 523–525 (1997).
Bruneel, J., D'Este, P. & Salter, A. Res. Policy 39, 858–868 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Johnston, S., Hauser, S. & Desmond-Hellmann, S. Enhancing ties between academia and industry to improve health. Nat Med 17, 434–436 (2011). https://doi.org/10.1038/nm0411-434
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0411-434
- Springer Nature America, Inc.
This article is cited by
-
Review: in vivo optical spectral tissue sensing—how to go from research to routine clinical application?
Lasers in Medical Science (2017)
-
Converging Technologies: A Critical Analysis of Cognitive Enhancement for Public Policy Application
Science and Engineering Ethics (2013)
-
The Innovative Medicines Initiative: A European Response to the Innovation Challenge
Clinical Pharmacology & Therapeutics (2012)